1. Home
  2. ZLAB vs CUBI Comparison

ZLAB vs CUBI Comparison

Compare ZLAB & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.68

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$78.83

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
CUBI
Founded
2013
1994
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
ZLAB
CUBI
Price
$25.68
$78.83
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$49.60
$85.00
AVG Volume (30 Days)
1.2M
193.0K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
22.99
EPS
N/A
4.02
Revenue
$460,156,000.00
N/A
Revenue This Year
$9.75
$24.95
Revenue Next Year
$26.03
$9.50
P/E Ratio
N/A
$20.17
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$59.34
52 Week High
$34.72
$84.38

Technical Indicators

Market Signals
Indicator
ZLAB
CUBI
Relative Strength Index (RSI) 58.33 48.57
Support Level $16.98 $71.61
Resistance Level $27.08 $79.38
Average True Range (ATR) 0.85 1.79
MACD -0.21 -0.07
Stochastic Oscillator 40.52 60.48

Price Performance

Historical Comparison
ZLAB
CUBI

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

Share on Social Networks: